| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1084020226 |
| P356 | DOI | 10.1007/S00262-017-1987-X |
| P698 | PubMed publication ID | 28349165 |
| P50 | author | Toshihiro Nagato | Q87684568 |
| P2093 | author name string | Hiroya Kobayashi | |
| Kensuke Oikawa | |||
| Naoko Aoki | |||
| Esteban Celis | |||
| Hidehiro Takei | |||
| Yui Hirata | |||
| Kei Ishibashi | |||
| Takumi Kumai | |||
| Yasuaki Harabuchi | |||
| Takayuki Ohkuri | |||
| Akemi Kosaka | |||
| Kan Kishibe | |||
| Miki Takahara | |||
| Seigo Ueda | |||
| Masatoshi Sado | |||
| Kenzo Ohara | |||
| Yuji Uno | |||
| Yuki Komabayashi | |||
| Naoko Akiyama | |||
| P433 | issue | 7 | |
| P921 | main subject | immunotherapy | Q1427096 |
| P304 | page(s) | 877-890 | |
| P577 | publication date | 2017-03-27 | |
| P1433 | published in | Cancer Immunology, Immunotherapy | Q5031409 |
| P1476 | title | Programmed death-ligand 1 and its soluble form are highly expressed in nasal natural killer/T-cell lymphoma: a potential rationale for immunotherapy | |
| P478 | volume | 66 |